Evaluation of 99mTc-ceftazidime as bacterial infection imaging agent

Journal of Radioanalytical and Nuclear Chemistry

Volumn 298, Issue 1, 2013, Pages 19-24

  Mirshojaei, S F ^a   Erfani, M ^a   Shafiei, M ^a  

^a NUCLEAR SCIENCE AND TECHNOLOGY RESEARCH INSTITUTE   (Iran)

Author keywords

Ceftazidime; Infection imaging; Radiolabeling

Indexed keywords

EID: 84885185688     PISSN: 02365731     EISSN: 15882780     Source Type: Journal    
DOI: 10.1007/s10967-013-2418-x     Document Type: Article

References (37)

1. Becker W (1995) The contribution of nuclear medicine to the patient with infection. Eur J Nucl Med 22(10):1195-1211
2. Das SS, Hall AV, Wareham DW, Britton KE (2002) Infection imaging with radiopharmaceuticals in the 21st century. Braz Arch Biol Technol 45:25-37
3. Pak KY, Nedelman MA, Tam SH, Wilson E, Daddona PE (1992) Labeling and stability of radiolabeled antibody fragments by a direct 99mTc-labeling method. Int J Rad Appl Instrum B 19(6):669-677
4. Signore A, D'Alessandria C, Annovazzi A, Scopinaro F (2002) Radiolabeled cytokines for imaging chronic inflammation. Braz Arch Biol Tech 45:15-23
5. Knight LC (2003) Non-oncologic applications of radiolabeled peptides in nuclear medicine. Q J Nucl Med 47(4):279-291
6. Weiner RE, Thakur ML (2001) Radiolabeled peptides in diagnosis and therapy. Semin Nucl Med 31(4):296-311
7. Cardoso VN, Plaza PJ, Roca M, Armero F, Martín-Comin J (2002) Assessment of inflammatory bowel disease by using two different (99 m)Tc leucocyte labeling methods. Nucl Med Commun 23(8):715-720
8. Yeaman MR, Yount NY (2003) Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55(1):27-55
9. Gandomkar M, Najafi R, Shafiei M, Mazidi M, Goudarzi M, Mirfallah SH, et al. (2009) Clinical evaluation of antimicrobial peptide [(99 m)Tc/Tricine/HYNIC(0)]ubiquicidin 29-41 as a human-specific infection imaging agent. Nucl Med Biol 36(2):199-205
10. Gandomkar M, Najafi R, Mazidi M, Goudarzi M, Mirfallah SH (2008) New peptid based freezed-dried kit [99 mTc-HYNIC]- UBI 29-41 as a human specific infection imaging agent. Iran J Nucl Med 16(1):25-30
11. Gandomkar M, Najafi R, Mazidi M, Mirfallah SH, Goudarzi M (2009) Three different procedures in labeling of Ubiquicidin with technetium 99m: a comparative study. Iran J Radiat Res 7(2):97-104
12. Martin-Comin J, Cardoso VN, Plaza P, Roca M (2002) Hank's balanced salt solution: an alternative resuspension medium to label autologous leukocytes. Braz Arch Biol Technol 45:39-44
13. Britton KE, Vinjamuri S, Hall AV, Solanki K, Siraj QH, Bomanji J, et al. (1997) Clinical evaluation of technetium-99m infecton for the localisation of bacterial infection. Eur J Nucl Med 24(5):553-556
14. Fournier B, Zhao X, Lu T, Drlica K, Hooper DC (2000) Selective targeting of topoisomerase IV and DNA gyrase in Staphylococcus aureus: different patterns of quinolone-induced inhibition of DNA synthesis. Antimicrob Agents Chemother 44(8):2160-2165
15. Mirshojaei SF, Erfani M, Najafi R, Babaei MH, Talebi MH (2011) J Radioanal Nucl Chem 287:21-25
16. Solanki KK, Bomanji J, Siraj Q, Small M, Britton KE (1993) J Nucl Med 34:119
17. Bhardwaj N, Bhatnagar A, Singh AK (2005) Development and evaluation of a single vial cold kit for infection imaging: Tc-99m ciprofloxacin. World J Nucl Med 4:244-251
18. Tavaras W (2002) Manual de antibioticos e quimioterapicos antiinfecciosos. Atheneu, Sao Paolo
19. Chattopadhay S, Das SS, Chandra S, De K, Mishra M, Sarkar BR, Sinha S, Ganguly S (2010) Appl Radiat Isot 68:314-317
20. Zhang J, Guo H, Zhang S, Lin Y, Wang X (2008) Bioorg Med Chem Lett 18:51-57
21. Roohi S, Moshtaq A, Jehangir M, Ashfagq MS (2006) J Radioanal Nucl Chem 267:561-566
22. El-Gany EA, El-Kolaly MT, Amine AM, El-Sayed AS, Abdel-Ghelil F (2005) J Radioanal Nucl Chem 266:131-135
23. Shah SQ, Khan AU, Khan MR (2010) Appl Radiat Isot 68:2255-2260
24. Shah SQ, Khan AU, Khan MR (2010) Radiochim Acta 99:53-58
25. Gandomkar M, Najafi R, Shafiei M, Mazidi M, Goudarzi M, Mirfallah SH (2009) Nucl Med Biol 36:199
26. Gandomkar M, Najafi R, Mazidi M, Mirfallah SH, Goudarzi M (2009) Nucl Med Biol 7(2):97
27. Barreto VG, Iglesias F, Roca M, Tubau F, Martin-Comin J (2000) Rev Esp Med Nucl 19:479
28. Shah SQ, Khan AU, Khan (2010) J Radioanal Nucl Chem. doi: 10.1007/s10967-010-0871-3
29. McAfee JG, Gagne G, Subramanian G, Schneider RF (1991) J Nucl Med 32:2126
30. Sampson CB (1996) Nucl Med Commun 17:648
31. Vallee F, Lebel M (1991) J Antimicrob Agents Chemother 35:2057
32. Sonmezoglu K, Sonmezoglu M, Halak M, Akgun I, Turkmen C, Onsel C, Kanmaz B, Solanki K, Britton KE (2001) J Nucl Med 42:567
33. Yapar Z, Kibar M, Yapar AF, Togrul E, Kayaselcuk U, Sarpel Y (2001) J Nucl med 28:822
34. Larikka MJ, Ahonen AK, Niemela O, Puronto O, Junila JA, Hamalainen MM, Britton KE, Syrajala HP (2002) Nucl Med Commun 23:655
35. Larikka MJ, Ahonen MK, Niemela O, Puronto O, Junila JA, Hamalainen MM, Britton KE, Syrajala HP (2002) Nucl Med Commun 23:655
36. Welling MM, Paulusma-Annema A, Balter HS, Pauwels EK, Nibbering PH (2000) Eur J Nucl Med 27:1865
37. Mirshojaei SF, Erfani M, Sadat Ebrahimi SE, Talebi MH, Hakj Hassan Abbasi F (2010) Iran J Nucl Med 2010 18(2):45